Jagged1-induced Notch activation contributes to the acquisition of bortezomib resistance in myeloma cells

[1]  Yong Fang,et al.  MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis , 2016, Oncotarget.

[2]  M. Saha,et al.  Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma , 2014, Leukemia.

[3]  Mamoru Ito,et al.  Effective expansion of engrafted human hematopoietic stem cells in bone marrow of mice expressing human Jagged1. , 2014, Experimental hematology.

[4]  Guoan Chen,et al.  Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms , 2013, Oncotarget.

[5]  M. Chiriva-Internati,et al.  Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes , 2013, Leukemia.

[6]  R. Zorec,et al.  Astrocytes Negatively Regulate Neurogenesis Through the Jagged1‐Mediated Notch Pathway , 2012, Stem cells.

[7]  Michele Cavo,et al.  Proteasome inhibitors in multiple myeloma: 10 years later. , 2012, Blood.

[8]  B. Klein,et al.  Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells. , 2012, Blood cells, molecules & diseases.

[9]  Iannis Aifantis,et al.  Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think , 2011, The Journal of experimental medicine.

[10]  Mamoru Ito,et al.  Establishment of a xenograft model of human myelodysplastic syndromes , 2011, Haematologica.

[11]  A. Palumbo,et al.  Multiple myeloma. , 2011, The New England journal of medicine.

[12]  Hong Chang,et al.  Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma , 2010, Journal of hematology & oncology.

[13]  Jesse C. Gatlin,et al.  Dynamic adhesions and MARCKS in melanoma cells , 2009, Journal of Cell Science.

[14]  Les Coulton,et al.  Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myeloma. , 2009, Cancer research.

[15]  D. Chauhan,et al.  Bone marrow microenvironment and the identification of new targets for myeloma therapy , 2009, Leukemia.

[16]  K. Kaestner,et al.  Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development , 2008, Proceedings of the National Academy of Sciences.

[17]  Mamoru Ito,et al.  Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. , 2006, Blood.

[18]  H. Nakauchi,et al.  Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[20]  H. Avet-Loiseau,et al.  Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. , 2004, Blood.

[21]  H. Stein,et al.  Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. , 2004, Blood.

[22]  Jay S. Fine,et al.  Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.

[23]  G. Higgins,et al.  Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. , 2004, The Journal of biological chemistry.

[24]  T. Kawamoto,et al.  Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. , 2003, Archives of histology and cytology.

[25]  M. Yamada,et al.  Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein , 2002, Journal of neurochemistry.

[26]  B. Trask,et al.  The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. , 1998, Immunity.